Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions

Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions

In the era of personalized medicine, the introduction of translational studies in clinical trials has substantially increased their costs, but provides the possibility of improving the productivity of trials with a better selection of recruited patients. With the overall goal of creating a roadmap t...

Full description

Bibliographic Details
Main Authors: Marina Bagnoli, Ting Yan Shi, Charlie Gourley, Paul Speiser, Alexander Reuss, Hans W. Nijman, Carien L. Creutzberg, Suzy Scholl, Anastassia Negrouk, Mark F. Brady, Kosei Hasegawa, Katsutoshi Oda, Iain A. McNeish, Elise C. Kohn, Amit M. Oza, Helen MacKay, David Millan, Katherine Bennett, Clare Scott, Delia Mezzanzanica
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Cells
Subjects:
translational studies design
gynecological cancers
biomarkers definition
precision medicine
samples collection
Online Access:https://www.mdpi.com/2073-4409/8/3/200

Internet

https://www.mdpi.com/2073-4409/8/3/200

Similar Items